Cayman Chemical, 1216744-19-2

1 - 1 of 1
Sort
View
Show
  • Cayman Chemical

    A synthetic agonist for REV-ERBα (EC50 = 0.4 μM) that mimics the action of heme; at 10 μM inhibits the expression of the circadian target gene bmal1 and reduces glucose output by 30% in mouse primary hepatocytes by repressing the expression of several gluconeogenic genes.